PSYENCE BIOMEDICAL LTD (PBM) Stock Overview
NASDAQ:PBM - CA74449F3088 - Common Stock
PBM Key Statistics, Chart & Performance
The current stock price of PBM is 2.81 USD. In the past month the price increased by 19.07%. In the past year, price decreased by -98.85%.
PBM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.68B | ||
| AMGN | AMGEN INC | 13.19 | 154.89B | ||
| GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
| INSM | INSMED INC | N/A | 28.77B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
| NTRA | NATERA INC | N/A | 23.09B | ||
| BIIB | BIOGEN INC | 8.26 | 19.38B |
Related stock screener links
About PBM
Company Profile
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Company Info
PSYENCE BIOMEDICAL LTD
121 Richmond Street West Penthouse, Suite 1300
TORONTO ONTARIO V6E 3Z3 CA
CEO: John Plourde
Employees: 12
Phone: 17744604171
PSYENCE BIOMEDICAL LTD / PBM FAQ
What is the stock price of PSYENCE BIOMEDICAL LTD today?
The current stock price of PBM is 2.81 USD. The price decreased by -5.39% in the last trading session.
What is the ticker symbol for PSYENCE BIOMEDICAL LTD stock?
The exchange symbol of PSYENCE BIOMEDICAL LTD is PBM and it is listed on the Nasdaq exchange.
On which exchange is PBM stock listed?
PBM stock is listed on the Nasdaq exchange.
What is PSYENCE BIOMEDICAL LTD worth?
PSYENCE BIOMEDICAL LTD (PBM) has a market capitalization of 2.00M USD. This makes PBM a Nano Cap stock.
How many employees does PSYENCE BIOMEDICAL LTD have?
PSYENCE BIOMEDICAL LTD (PBM) currently has 12 employees.
Should I buy PSYENCE BIOMEDICAL LTD (PBM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PBM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PBM, evaluating the profitability, health, valuation and growth aspects
- PSYENCE BIOMEDICAL LTD (PBM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PSYENCE BIOMEDICAL LTD (PBM) Sales and EPS estimates to see what analysts future expectations are.
- PSYENCE BIOMEDICAL LTD (PBM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PSYENCE BIOMEDICAL LTD (PBM) Insider and Institutional Ownership to learn about the owners and their transactions.
- PSYENCE BIOMEDICAL LTD (PBM) Stock Chart to make your own analysis
- PSYENCE BIOMEDICAL LTD (PBM) Latest news and press-releases to stay up to date.
Does PSYENCE BIOMEDICAL LTD (PBM) stock pay dividends?
PBM does not pay a dividend.
What is the Short Interest ratio of PSYENCE BIOMEDICAL LTD (PBM) stock?
The outstanding short interest for PSYENCE BIOMEDICAL LTD (PBM) is 0.86% of its float. Check the ownership tab for more information on the PBM short interest.
PBM Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PBM. When comparing the yearly performance of all stocks, PBM is a bad performer in the overall market: 99.09% of all stocks are doing better.
PBM Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |